Protective effect of defibrotide on perfusion induced endothelial damage (Q30912537)

27 June 2017

title

Protective effect of defibrotide on perfusion induced endothelial damage (English)

1 reference

27 June 2017

0 references

T San

1

1 reference

27 June 2017

H Moini

series ordinal

2

1 reference

27 June 2017

K Emerk

series ordinal

3

1 reference

27 June 2017

S Bilsel

series ordinal

4

1 reference

27 June 2017

publication date

1 August 2000

1 reference

27 June 2017

1 reference

27 June 2017

volume

99

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

335-341

1 reference

Defibrotide decreases cholesterol amount in hypercholesterolemic rabbit aorta, with no modification of plasma or lipoprotein cholesterol

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Effects of defibrotide on leukocytosis in rabbits with diet-induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Chronic oral defibrotide counteracts hypercholesterolemia noxious effects on cardiovascular function in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Morphological changes in carotid arteries of rabbits induced by defibrotide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Ruthenium red and violet. II. Fine structural localization in animal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Polydeoxyribonucleotides and nitric oxide release from guinea‐pig hearts during ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Activation of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900256-5

7 January 2021

10.1016/S0049-3848(00)00256-5

Identifiers

DOI

1 reference

release_ghsqgsg7f5efdidhgh7op3oifq

27 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ghsqgsg7f5efdidhgh7op3oifq

24 November 2022

mapped directly with Wikidata item

1 reference